|
|
 |
|
Viewing report
|
|
|
|
Disease and Therapy Review: Non-Small Cell Lung Cancer
Timely Data Resources, Inc., July 2008, Pages: 11
The Non-Small Cell Lung Cancer (NSCLC) Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments by disease stage. General sales information is included for several chemotherapy agents, although not broken out for NSCLC specifically.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Customers who bought this item also bought
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report
Lung Cancer, 3rd Edition
Disease and Therapy Review: Chronic Obstructive Pulmonary Disease
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer
Cell Therapy - Technologies, Markets and Companies
Gene Therapy - Technologies, Markets and Companies
Cancer Cell Therapy Markets
Looking at the Cancer Therapy Market
Treatment Algorithms 2001: Lung Cancer
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma
Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus Lung Cancer and Melanoma
|
|
|
|
